ADMA Biologics, Inc. (ADMA)
15.52
-0.77
(-4.73%)
USD |
NASDAQ |
Feb 24, 16:00
15.70
+0.18
(+1.16%)
Pre-Market: 08:30
ADMA Biologics Free Cash Flow : 40.61M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Marker Therapeutics, Inc. | -14.82M |
| Arcutis Biotherapeutics, Inc. | -48.24M |
| CorMedix, Inc. | 74.42M |
| AtriCure, Inc. | 48.28M |
| Ligand Pharmaceuticals, Inc. | 20.43M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 13.29M |
| Cash from Investing (Quarterly) | -14.37M |
| Cash from Financing (Quarterly) | -27.82M |
| Free Cash Flow Per Share (Quarterly) | -0.0044 |
| Free Cash Flow to Equity (Quarterly) | -0.373M |
| Free Cash Flow to Firm (Quarterly) | 0.2092M |
| Free Cash Flow Yield | 1.06% |